Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03394365 |
|---|---|
| Brief Title: | Tabelecleucel for Solid Organ or Allogeneic Hematopoietic Cell Transplant Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) After Failure of Rituximab or Rituximab and Chemotherapy (ALLELE) |
| First Submitted : | December 29, 2017 |
| First Submitted that Met QC Criteria : | January 4, 2018 |
| First Posted : | January 9, 2018 |
| Last Update Submitted that Met QC Criteria : | March 24, 2021 |
| Last Update Posted : | March 26, 2021 |